Developmental Therapeutics

7 currently open clinical trials
A phase I trial with TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors
SAKK 65/16
Stimulating the immune system to fight against squamous cell carcinoma
SAKK 11/16
Trial with the ATR Inhibitor BAY-1895344 in Patients with advanced solid Tumors and Lymphomas (first use in humans)
SAKK 69/17
Alpine Tumor Immunology Registry
SAKK 80/19 Alpine TIR
Treatment of advanced non-small cell lung cancer or of mesothelioma with gemcitabine and atezolizumab
SAKK 17/18
Therapy with docetaxel micellar in metastatic, castration-resistant prostate cancer
SAKK 67/20
ATR Inhibitor BAY-1895344 in combination with Pembrolizumab in patients with advanced solid tumors
SAKK 69/20
All cancer types